Cold & Cough Remedies - United Arab Emirates

United Arab Emirates

Highlights

In the United Arab Emirates, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$100.30m.
It is projected that the market will experience an annual growth rate of 7.17% (CAGR 2024-2029).
When compared to the global market, the United States generates the highest revenue in this market, with a total of US$11.19bn in 2024.
In terms of per capita revenue, in 2024, each person in the United Arab Emirates generates US$10.45 in Cold & Cough Remedies market market revenue.
The demand for Cold & Cough Remedies in the United Arab Emirates has surged due to the high prevalence of respiratory illnesses and the country's growing population.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Cold & Cough Remedies market in United Arab Emirates is experiencing steady growth due to changing customer preferences and increasing awareness about the importance of maintaining good health.

Customer preferences: Customers in United Arab Emirates are becoming more health-conscious and are actively seeking remedies to alleviate cold and cough symptoms. They prefer products that are effective in providing relief and have minimal side effects. Additionally, customers are increasingly opting for natural and herbal remedies as they perceive them to be safer and more gentle on their bodies.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in United Arab Emirates is the growing demand for over-the-counter (OTC) medications. Customers are increasingly self-diagnosing their symptoms and prefer to purchase medications without the need for a prescription. This trend is driven by convenience and the desire for immediate relief. As a result, pharmaceutical companies are focusing on developing and marketing OTC cold and cough remedies to cater to this demand.Another trend in the market is the increasing popularity of natural and herbal remedies. Customers are seeking alternatives to traditional medications and are turning to natural ingredients such as honey, ginger, and herbal extracts. This trend is driven by the perception that natural remedies are safer and have fewer side effects. As a response to this trend, pharmaceutical companies are launching products that incorporate natural ingredients to cater to the growing demand.

Local special circumstances: The United Arab Emirates has a high expatriate population, with people from different countries residing in the country for work or leisure purposes. This diverse population brings with them different cultural practices and preferences for cold and cough remedies. As a result, the market in United Arab Emirates is characterized by a wide variety of products catering to different customer preferences.

Underlying macroeconomic factors: The growing population and increasing urbanization in United Arab Emirates are key macroeconomic factors driving the growth of the Cold & Cough Remedies market. As the population continues to grow, the demand for healthcare products, including cold and cough remedies, is expected to increase. Additionally, the rising disposable income of the population enables them to afford healthcare products and invest in their well-being.Furthermore, the government's focus on healthcare and wellness initiatives is also contributing to the growth of the market. The government is actively promoting preventive healthcare measures and raising awareness about the importance of maintaining good health. This has led to an increase in the adoption of cold and cough remedies as part of a proactive approach to health management.In conclusion, the Cold & Cough Remedies market in United Arab Emirates is experiencing growth due to changing customer preferences, including the preference for OTC medications and natural remedies. The market is also influenced by the diverse population and the government's focus on healthcare and wellness initiatives. As the population continues to grow and become more health-conscious, the market is expected to expand further in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.